期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Dyslipidemia: evidence of efficacy of the pharmacological and non-pharmacological treatment in the elderly 被引量:3
1
作者 Claudia F Gravina Marcelo Bertolami giselle hp rodrigues 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2012年第2期83-90,共8页
The clinical decision to control risk factors for cardiovascular disease (CVD) in the elderly takes the followings into consideration: (1) the elderly life expectancy; (2) the elderly biological age and functio... The clinical decision to control risk factors for cardiovascular disease (CVD) in the elderly takes the followings into consideration: (1) the elderly life expectancy; (2) the elderly biological age and functional capacity; (3) the role of cardiovascular disease in the elderly group; (4) the prevalence of risk factors in the elderly; and (5) The effectiveness of treatment of risk factors in the elderly. A large number of studies showed the efficacy of secondary and primary prevention of dyslipidemia in the elderly. However, the only trial that included patients over 80 years was the Heart Protection Study (HPS). Statins are considered the first line therapy for lowering low-density lipoprotein cholesterol (LDL-C). Because lifestyle changes are very difficult to achieve, doctors in general tend to prescribe many drugs to control cardiovascular risk factors. However, healthy food consumption remains a cornerstone in primary and secondary cardiovascular prevention and should be implemented by everyone. 展开更多
关键词 Elderly patient Risk factors DYSLIPIDEMIA Cardiovascular disease DIET
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部